US Federal House Bill HB4981

US Federal 2025-2026 Regular Session

• Introduced: 8/15/25
• Refer: 8/15/25

Caption

Stamp Out Lyme Disease Act

Impact

If enacted, HB 4981 would have significant implications for state laws surrounding public health and disease awareness. The bill would authorize funding for public education campaigns and collaborations with healthcare providers and community organizations. This could lead to an increase in the overall awareness of Lyme disease, which may result in early detection and treatment, ultimately reducing healthcare costs associated with delayed care. The initiative is expected to equip the public with necessary knowledge to prevent infections and recognize symptoms more effectively.

Summary

House Bill 4981, known as the Stamp Out Lyme Disease Act, is aimed at enhancing public health measures related to the prevention and awareness of Lyme disease and other tick-borne illnesses. The bill proposes the implementation of educational programs and initiatives that raise awareness about the symptoms, prevention, and treatment of Lyme disease. It seeks to engage local communities in disease prevention strategies and promote research that could lead to better understanding and mitigation of tick-related health risks. By highlighting this health issue, the bill aims to reduce the incidence and impact of Lyme disease statewide.

Contention

The discussions surrounding HB 4981 have seen various stakeholders express both support and concern. Proponents, including public health advocates and medical professionals, argue that this bill is essential in combating a growing public health concern that is often overlooked. However, some critics have raised concerns regarding budget allocations, questioning whether the resources dedicated to this initiative might detract from funding for other pressing health issues. They argue for a more balanced approach to public health funding, highlighting the need for comprehensive healthcare services beyond just disease-specific campaigns.